Goldman Sachs Maintains Buy on Legence, Raises Price Target to $63

Benzinga Newsdesk www.benzinga.com Positive 79.6%

Neg 0% Neu 0% Pos 79.6%

Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $52 to $63.

Comments

No comments yet. Be the first!